CClinicalTrials.gg
CompletedNCT05144906Updated Jul 6, 2022

Implicit Attitudes Toward Body Shape Among Blind Women

An observational study in Blindness and Implicit Bias, sponsored by University of Haifa. Completed at 1 site in Israel. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-06.

Sponsored by University of Haifa · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
64
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

High levels of body image concerns and disordered eating in western women have been associated with the promotion of an unrealistically thin body ideal. The pressure to conform with the thin-ideal forms both explicit and implicit attitudes favoring thinness. Visual-based media depicting thin-idealized bodies plays a major role in forming such attitudes. However, attitudes favoring thinness can also be transmitted through non-visual communication such as peer pressure and significant others. The current study will examine if implicit attitudes favoring thinness and disliking overweight bodies can be formed without ever being exposed to visual-based media or being visually exposed to body shapes. To achieve this goal, the study will assess implicit attitudes towards thin and overweight bodies in congenitally blind women and those who were blinded early in life. The assessment will be carried out using a novel auditory weight-bias implicit association test.

Read the detailed description

Previous studies have demonstrated strong implicit associations between images portraying thin bodies and positive words and images portraying overweight bodies and negative words among healthy individuals in Western society. This so-called "implicit weight bias" is thought to represent individuals' unconscious or automatic stereotypical attitudes against being overweight. The goal of the current study is to examine implicit weight biases among congenitally blind as well as sighted women using a novel auditory version of the weight bias implicit association task. In this task, participants hear a series of words and are requested to classify each word using a motor response to the matching category. The categories used will be negative and positive words as well as words describing thin and overweight bodies. Implicit anti-fat bias is reflected by longer response times and higher error rates, when positive words and those describing overweight bodies require the same motor response and when negative words are coupled with words describing thin bodies compared to when positive and negative words are coupled with words describing thin and overweight bodies, respectively.

The investigators have collected preliminary results in a sample of blind women (N = 18) in Israel. The investigators plan to a) expand the data collection in Israel to reach a sample of 30 blind women and to b) carry out a full replication of the study in an independent sample of blind and sighted women in the US. Data have not been collected yet for the US replication study. Based on the effect size of the the implicit bias effect (represented by the IAT D score) obtained in preliminary results in the Israeli sample (Cohen's D = 0.74), a power analysis using G*power was carried out and showed that a sample of 22 participants is sufficient to detect the IAT implicit bias effect with a power > 95% and an a-priori alpha set at 0.05.

Based on preliminary results in the Israeli sample, it is hypothesized that:

  1. Blind women will demonstrate an implicit bias indicating preference for thin bodies and a dislike of overweight bodies. This effect will be reflected by slower response times when words describing thin bodies will be coupled with negative compared to positive words and when words describing overweight bodies will be coupled with positive compared to negative words. This implicit bias effect will be computed using the IAT's D algorithm.
  2. The implicit anti-fat bias effect (IAT D-score) will be comparable between sighted and blind women.
02

Conditions studied

  • Blindness
  • Implicit Bias

Browse trials for

03

In context

Blindness

161 studies on the registry are indexed under Blindness; 33 are open to participants now.

This study's enrollment of 64 is close to the median of 64 across 45 observational studies indexed under Blindness.

Browse Blindness studies →

Lead sponsor

University of Haifa is the lead sponsor of 101 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The blind women group will only include women who were blinded earlier than the age of 7 and cannot see themselves in the mirror not recognize other people's faces or bodies or use visual-based media. The sighted women group will include women with normal or corrected-to-normal vision.

Eligibility criteria

Blind Women

Inclusion Criteria:

  • Aged 18-45 years.
  • Congenitally blind or blinded no later than the age of 7.
  • Inability to see themselves in the mirror.
  • Inability to recognize other people's faces or bodies.
  • Inability to use visual-based media.
  • Fluent English speakers.

Exclusion Criteria:

  • Any condition that prevents the ability to use a computer.

Sighted women

Inclusion Criteria:

  • Aged 18-45 years old.
  • Corrected or corrected-to-normal vision.
  • Fluent English speakers.

Exclusion Criteria:

  • Any condition that prevents the ability to use a computer.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
64 participants (actual)
Patient registry
No

Groups and cohorts

  • Blind women

    The blind women group will include women who are congenitally blind or that were blinded early in life (up to the age of 7).

  • Sighted women

    Women with normal or corrected-to-normal eye sight.

06

What researchers measure

Primary outcomes

  1. Implicit Association Test

    IAT D-Score calculated for assessing an implicit weight bias. The IAT D score will be computed using the improved algorithm suggested by Greenwald et al. (2003). According to this algorithm, RTs longer than 10,000 ms will be deleted. Participants with more than 10% of the trials that are shorted than 300 ms will be excluded from the analysis. Mean RTs for correct trials will be computed for each block separately. Error trials will be replaced by the mean score of each block + 600 ms. Then, the difference in RTs between the practice stereotype incongruent and practice congruent conditions will be divided by their pooled SD. Then, the different in RTs between the test stereotype congruent and incongruent blocks will be divided by their pooled RTs. Lastly, the two scores form the practice and test blocks will be averaged to compute the IAT D score.

    Time frame: One assessment at baseline after study information and informed consent was given

Secondary outcomes

  1. Sociocultural Attitudes Toward Appearance Questionnaire-4 (SATAQ-4R)

    The SATAQ-4R is a gender-specific self-report tool composed of 31 items in the female version. It includes four scales to evaluate the perceived pressure from family, peers, significant others, and the media to attain a thin body and three sub-scales that evaluate the desire to attain a lean body, to attain a muscular physique and overall concern with personal appearance. Participants rate their agreement with various statements on a 5-point scale.

    Time frame: up to 72 hours after completion of the baseline assessment

  2. Ideal Body Stereotype Scale-Revised (IBSS-R)

    The IBSS-R measures the pursuit of the thin beauty ideal. Participants are asked to indicate to what extent they agree with six statements about what attractive women look like on a 5-point scale from strongly disagree to strongly agree. The total sum ranges from 0 to 30 with higher scores indicating a stronger internalization of the thin ideal.

    Time frame: up to 72 hours after completion of the baseline assessment

  3. Body Parts Dissatisfaction Scale (BPDS)

    The BPDS assesses body dissatisfaction by asking the respondents to rate their satisfaction with 9 body parts on a scale from 1 (extremely dissatisfied) to 5 (extremely satisfied). Lower scores represent greater body dissatisfaction.

    Time frame: up to 72 hours after completion of the baseline assessment

  4. Body mass index (BMI)

    Weight and height data will be collected via self-report in order to calculate BMI (kg/cm2).

    Time frame: up to 72 hours after completion of the baseline assessment

07

Study locations

1 site
  • University of Haifa
    Haifa, Central 3600100, Israel
08

References and documents

Individual participant data

Plan to share: Yes — The study will provide open access for de-identified data as well as for the analytical plan and protocol.

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05144906
Lead sponsor
University of Haifa
Responsible party
Sponsor
First posted
Dec 3, 2021
Start date
Dec 1, 2021
Primary completion
Jun 15, 2022
Completion
Jun 15, 2022
Last update
Jul 6, 2022

Study contacts

Noam Weinbach, PhD
principal investigator · University of Haifa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion